Insider Buying: Zimmer Biomet Holdings Inc (ZBH) Insider Purchases $3,001,215.36 in Stock

Zimmer Biomet Holdings Inc (NYSE:ZBH) insider Bryan C. Hanson acquired 25,077 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The shares were purchased at an average price of $119.68 per share, with a total value of $3,001,215.36. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Zimmer Biomet Holdings Inc (NYSE ZBH) opened at $117.58 on Friday. The firm has a market cap of $23,810.00, a P/E ratio of 44.71, a PEG ratio of 2.08 and a beta of 1.08. Zimmer Biomet Holdings Inc has a 1-year low of $108.03 and a 1-year high of $133.49. The company has a quick ratio of 0.83, a current ratio of 1.52 and a debt-to-equity ratio of 0.76.

Zimmer Biomet (NYSE:ZBH) last released its quarterly earnings results on Tuesday, January 30th. The medical equipment provider reported $2.10 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $2.10. The company had revenue of $2.07 billion during the quarter, compared to analysts’ expectations of $2.03 billion. Zimmer Biomet had a net margin of 23.51% and a return on equity of 15.45%. The business’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.14 earnings per share. sell-side analysts expect that Zimmer Biomet Holdings Inc will post 7.82 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Monday, January 29th. Stockholders of record on Friday, December 29th were issued a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 0.82%. The ex-dividend date was Thursday, December 28th. Zimmer Biomet’s dividend payout ratio (DPR) is presently 36.50%.

A number of research analysts recently issued reports on ZBH shares. Morgan Stanley boosted their price objective on shares of Zimmer Biomet from $140.00 to $150.00 in a report on Monday, January 29th. Deutsche Bank upgraded shares of Zimmer Biomet from a “hold” rating to a “buy” rating and set a $128.00 price objective for the company in a report on Tuesday, November 14th. Edward Jones upgraded shares of Zimmer Biomet from a “hold” rating to a “buy” rating in a report on Thursday, November 9th. Jefferies Group restated a “buy” rating and set a $136.00 price objective on shares of Zimmer Biomet in a report on Friday, November 3rd. Finally, SunTrust Banks set a $136.00 price objective on shares of Zimmer Biomet and gave the company a “buy” rating in a report on Wednesday, November 1st. Two analysts have rated the stock with a sell rating, four have assigned a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $141.67.

Several hedge funds have recently made changes to their positions in the company. Longview Partners Guernsey LTD lifted its position in shares of Zimmer Biomet by 6.9% in the fourth quarter. Longview Partners Guernsey LTD now owns 8,027,808 shares of the medical equipment provider’s stock worth $968,716,000 after purchasing an additional 521,124 shares in the last quarter. Nordea Investment Management AB lifted its position in shares of Zimmer Biomet by 7.3% in the third quarter. Nordea Investment Management AB now owns 5,277,660 shares of the medical equipment provider’s stock worth $617,961,000 after purchasing an additional 357,302 shares in the last quarter. American Century Companies Inc. lifted its position in shares of Zimmer Biomet by 14.7% in the fourth quarter. American Century Companies Inc. now owns 4,777,397 shares of the medical equipment provider’s stock worth $576,488,000 after purchasing an additional 612,044 shares in the last quarter. Jana Partners LLC lifted its position in shares of Zimmer Biomet by 16.6% in the third quarter. Jana Partners LLC now owns 4,662,497 shares of the medical equipment provider’s stock worth $545,932,000 after purchasing an additional 662,497 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its position in shares of Zimmer Biomet by 24.4% in the third quarter. Bank of New York Mellon Corp now owns 2,759,704 shares of the medical equipment provider’s stock worth $323,134,000 after purchasing an additional 541,102 shares in the last quarter. 88.18% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “Insider Buying: Zimmer Biomet Holdings Inc (ZBH) Insider Purchases $3,001,215.36 in Stock” was originally reported by BBNS and is owned by of BBNS. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://baseballnewssource.com/markets/insider-buying-zimmer-biomet-holdings-inc-zbh-insider-purchases-3001215-36-in-stock/1907691.html.

About Zimmer Biomet

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish


Leave a Reply

 
© 2006-2018 BBNS.